About Proxima Ventures
Proxima Ventures is a private equity firm founded in 2016. It is primarily based in Taipei, Taiwan. In the last 12 months, it has participated in 2 funding rounds.
Overall Proxima Ventures portfolio has seen 1 IPO, namely Ningbo Bio Technology. A lot of funds co-invest with Proxima Ventures, with names like FutureX sharing a substantial percentage of its portfolio.
Proxima Ventures has a team of 20 people, including 7 partners.
Key Metrics
Proxima Ventures' Portfolio
They have invested in a total of 56 companies. Their most recent investment was in Huarong Science Technology Innovation (Series A round) on Jun 02, 2026. Here is the most recent investment by Proxima Ventures:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Jun 02, 2026 | Series A | 4755 | - | |
Sep 05, 2025 | Series A | 1291 | ||
Feb 24, 2025 | Unattributed | 4963 | - | |
Jan 17, 2025 | Series A | 7180 |
Here is the portfolio snapshot of Proxima Ventures:
Investments by Year
The maximum number of investments were made in 2022
Team profile of Proxima Ventures
Proxima Ventures has a team of 20 members including 7 Partners, 2 Venture Partners and 5 Principals located in China. Proxima Ventures' team does not sit on the board of any company as of now.Here is a list of top team members in Proxima Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Jinzhong | - | ||
Partner | China | - | ||
Partner | Minhang | - | ||
Partner | - | - | ||
Partner | - | - | ||
Partner | - | - | ||
Partner | - | - | ||
Venture Partner | - | - | ||
Venture Partner | - | - | ||
Principal | - | - | ||
Principal | - | - |
Co-investors of Proxima Ventures
Over the past 10 years, 71 investors have co-invested in Proxima Ventures's portfolio companies.
- Top Co-investors of Proxima Ventures: 71 investors entered a company along with Proxima Ventures. These include investors like FutureX (3 companies).
Proxima Ventures News
•
•
BridGene Biosciences Closes $28M Series B+Massinvestor•Jan 27, 2026•Lapam Capital, GTJAI, BridGene Biosciences, Proxima Ventures and 1 other
•
•
BridGene Biosciences Raises $28M in Series B+ FundingFinSMEs•Oct 16, 2025•Lapam Capital, GTJAI, BridGene Biosciences, Proxima Ventures and 3 others
•
Rapafusyn Pharmaceuticals Closes $44 Million Series A Financing for Molecular Glue Drug Discovery PlatformAgencia EFE•Sep 04, 2025•Rapafusyn, Yonjin Capital, BioTrack Capital, 3E Bioventures Capital and 5 others
•
Tuanxiang Pharmaceutical completes tens of millions of RMB Pre-A round financingfromgeek.com•Feb 24, 2025•Proxima Ventures
•
•
•
•

